Survival in Lung Cancer in the Nordic Countries Through A Half Century

References

• Polednak A. Trends in cancer incidence in Connecticut, 1935–1991. Cancer. 1994;74:2863–2872. doi:10.1002/1097-0142(19941115)74:10<2863::AID-CNCR2820741020>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect. 1995;103(Suppl8):131–142. doi:10.1289/ehp.95103s8131
   PubMedGoogle Scholar
• Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96–101. doi:10.1136/tobaccocontrol-2011-050294
   PubMed Web of Science ®Google Scholar
• Lipfert FW, Wyzga RE. Longitudinal relationships between lung cancer mortality rates, smoking, and ambient air quality: a comprehensive review and analysis. Crit Rev Toxicol. 2019;49(9):790–818. doi:10.1080/10408444.2019.1700210
   PubMed Web of Science ®Google Scholar
• IARC. Personal Habits and Indoor Combustions. Lyon: International Agency for Research on Cancer; 2012:575.
   Google Scholar
• Tindle HA, Stevenson Duncan M, Greevy RA, et al. Lifetime smoking history and risk of lung cancer: results from the Framingham heart study. J Natl Cancer Inst. 2018;110(11):1201–1207. doi:10.1093/jnci/djy041
   PubMedGoogle Scholar
• Hemminki K, Försti A, Hemminki A, Ljungberg B, Hemminki O. Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years. PLoS One. 2022;17(1):e0261124. doi:10.1371/journal.pone.0261124
   PubMed Web of Science ®Google Scholar
• Patja K, Hakala SM, Boström G, Nordgren P, Haglund M. Trends of tobacco use in Sweden and Finland: do differences in tobacco policy relate to tobacco use? Scand J Public Health. 2009;37(2):153–160. doi:10.1177/1403494808100277
   PubMed Web of Science ®Google Scholar
• Collaborators G. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–1906. doi:10.1016/S0140-6736(17)30819-X
   PubMed Web of Science ®Google Scholar
• Park SY, Lee JG, Kim J, et al. The influence of smoking intensity on the clinicopathologic features and survival of patients with surgically treated non-small cell lung cancer. Lung Cancer. 2013;81(3):480–486. doi:10.1016/j.lungcan.2013.07.002
   PubMed Web of Science ®Google Scholar
• Okamoto T, Suzuki Y, Fujishita T, et al. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma. Lung Cancer. 2014;85(2):125–130. doi:10.1016/j.lungcan.2014.06.006
   PubMed Web of Science ®Google Scholar
• Bergman M, Fountoukidis G, Smith D, Ahlgren J, Lambe M, Valachis A. Effect of smoking on treatment efficacy and toxicity in patients with cancer: a systematic review and meta-analysis. Cancers. 2022;14:17. doi:10.3390/cancers14174117
   Google Scholar
• Turner MC, Andersen ZJ, Baccarelli A, et al. Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA Cancer J Clin. 2020;70(6):460–479. doi:10.3322/caac.21632
   Web of Science ®Google Scholar
• Frank C, Fallah M, Ji J, Sundquist J, Hemminki K. The population impact of familial cancer, a major cause of cancer. Int J Cancer. 2014;134:1899–1906. doi:10.1002/ijc.28510
   PubMed Web of Science ®Google Scholar
• Liu X, Hemminki K, Forsti A, Sundquist K, Sundquist J, Ji J. Cancer risk in patients with type 2 diabetes mellitus and their relatives. Int J Cancer. 2015;137:903–910.
   PubMed Web of Science ®Google Scholar
• Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–795. doi:10.1016/j.eururo.2018.09.001
   PubMed Web of Science ®Google Scholar
• Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130–1141. doi:10.1038/s41416-018-0029-6
   PubMed Web of Science ®Google Scholar
• Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ. 2005;330(7485):223. doi:10.1136/bmj.38308.477650.63
   PubMed Web of Science ®Google Scholar
• Lorenzo-Gonzalez M, Ruano-Ravina A, Torres-Duran M, et al. Lung cancer risk and residential radon exposure: a pooling of case-control studies in northwestern Spain. Environ Res. 2020;189:109968. doi:10.1016/j.envres.2020.109968
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–736. doi:10.3109/02841861003782017
   PubMed Web of Science ®Google Scholar
• Pukkala E, Engholm G, Hojsgaard Schmidt LK, et al. Nordic Cancer Registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–455. doi:10.1080/0284186X.2017.1407039
   PubMed Web of Science ®Google Scholar
• Larønningen S, Ferlay J, Beydogan H, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries. Association of the Nordic cancer registries. Cancer Registry of Norway; 2022.
   Google Scholar
• Lundberg FE, Andersson TM, Lambe M, et al. Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies. Acta Oncol. 2020;59(11):1266–1274. doi:10.1080/0284186X.2020.1822544
   PubMed Web of Science ®Google Scholar
• Tichanek F, Försti A, Liska V, Hemminki A, Hemminki K. Survival in colon, rectal and small intestinal cancers in the Nordic countries through a half century. Cancers. 2023;15:3. doi:10.3390/cancers15030991
   Web of Science ®Google Scholar
• Hemminki J, Försti A, Hemminki A, Hemminki K. Survival trends in solid cancers in the Nordic countries through 50 years. Eur J Cancer. 2022;175:77–85. doi:10.1016/j.ejca.2022.08.015
   PubMed Web of Science ®Google Scholar
• Sachs E, Sartipy U, Jackson V. Sex and survival after surgery for lung cancer: a Swedish nationwide cohort. Chest. 2021;159(5):2029–2039. doi:10.1016/j.chest.2020.11.010
   PubMed Web of Science ®Google Scholar
• Nilssen Y, Strand TE, Fjellbirkeland L, Bartnes K, Møller B. Lung cancer survival in Norway, 1997–2011: from nihilism to optimism. Eur Respir J. 2016;47(1):275–287. doi:10.1183/13993003.00650-2015
   PubMed Web of Science ®Google Scholar
• Löfling L, Bahmanyar S, Kieler H, Lambe M, Wagenius G. Temporal trends in lung cancer survival: a population-based study. Acta Oncol. 2022;61(5):625–631. doi:10.1080/0284186X.2021.2013529
   PubMed Web of Science ®Google Scholar
• Leskelä RL, Peltonen E, Haavisto I, et al. Trends in treatment of non-small cell lung cancer in Finland 2014–2019. Acta Oncol. 2022;61(5):641–648. doi:10.1080/0284186X.2022.2042474
   PubMed Web of Science ®Google Scholar
• Solberg S, Nilssen Y, Brustugun OT, et al. Increase in curative treatment and survival of lung cancer in Norway 2001–2016. Eur J Epidemiol. 2019;34(10):951–955. doi:10.1007/s10654-019-00536-z
   PubMed Web of Science ®Google Scholar
• Borg M, Hilberg O, Andersen MB, Weinreich UM, Rasmussen TR. Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings. Acta Oncol. 2022;61(10):1256–1262. doi:10.1080/0284186X.2022.2135134
   PubMed Web of Science ®Google Scholar
• Maconachie R, Mercer T, Navani N, McVeigh G. Lung cancer: diagnosis and management: summary of updated NICE guidance. BMJ. 2019;364:1049. doi:10.1136/bmj.l1049
   Google Scholar
• Sørensen JB, Horvat P, Rosenlund M, et al. Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005–2015): SCAN-LEAF study. Future Oncol. 2022;18(2):205–214. doi:10.2217/fon-2021-0746
   PubMed Web of Science ®Google Scholar
• Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians--a national Danish project. Health Policy. 2012;105(1):65–70. doi:10.1016/j.healthpol.2011.11.001
   PubMed Web of Science ®Google Scholar
• Hemminki K, Försti A, Hemminki O, Liska V, Hemminki A. Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries. JHEP Rep. 2022;4(12):100602. doi:10.1016/j.jhepr.2022.100602
   PubMedGoogle Scholar
• Hemminki K, Försti A, Hemminki A, Ljungberg B, Hemminki O. Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic. Eur J Cancer Prev. 2022;31(3):228–234. doi:10.1097/CEJ.0000000000000694
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (Concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075. doi:10.1016/S0140-6736(17)33326-3
   PubMed Web of Science ®Google Scholar
• Lundberg FE, Birgisson H, Johannesen TB, et al. Survival trends in patients diagnosed with colon and rectal cancer in the Nordic countries 1990–2016: the NORDCAN survival studies. Eur J Cancer. 2022;172:76–84. doi:10.1016/j.ejca.2022.05.032
   PubMed Web of Science ®Google Scholar